| Financial Year |
March 31 2023 |
| Monetary Funds |
1,146,838,865.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
51,300,000.00 |
| Accounts Receivable |
926,317,288.05 |
| Advances to Suppliers |
1,007,067,188.43 |
| Other Receivables |
133,205,430.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,882,250,427.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
410,060,165.31 |
| Total Current Assets |
10,622,438,961.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
436,716,454.73 |
| Investment Properties |
-- |
| Fixed Assetes |
8,313,469,652.21 |
| Under-construction Projects |
113,834,615.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
611,154,540.28 |
| R&D expenses |
1,497,312.74 |
| Goodwill |
366,044,719.46 |
| Long-Term Deferred and Prepaid Expenses |
32,455,373.94 |
| Deferred Income Tax Assets |
172,043,506.57 |
| Other Non-Current Assets |
183,403,905.73 |
| Sub-Total of Non-Current Assets |
10,434,295,327.39 |
| Total Assets |
21,056,734,288.86 |
| Short-Term Loans |
5,891,209,837.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
47,718,649.10 |
| Accounts Payable |
865,710,313.91 |
| Accounts Received In Advance |
372,380.67 |
| Employee Compensation Payable |
194,406,172.10 |
| Taxes Payable |
97,035,093.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
569,119,280.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,813,076.81 |
| Other Current Liabilities |
37,079,082.30 |
| Sub-Total of Current Liabilities |
8,071,829,841.44 |
| Long-term Loans |
193,284,288.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,555,043.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,297,488.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
425,858,389.53 |
| Total Liabilities |
8,497,688,230.97 |
| Paid-In Capital(Or Share Stock) |
1,864,720,561.00 |
| Capital Surplus |
6,133,085,561.77 |
| Surplus Reserve |
297,880,951.15 |
| LESS:Treasury Stock |
40,728,571.81 |
| Undistributed Profits |
3,164,648,647.98 |
| Minority Stockholder's Interest |
453,192,342.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,105,853,715.24 |
| Owner's Equity（Stockholder's Equity） |
12,559,046,057.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,056,734,288.86 |
